The changing epidemiology of Acinetobacter spp. producing MA. carbapenemases causing bloodstream infections in Brazil: a BrasNet report

Imagem de Miniatura
Arquivos
art_VASCONCELOS_The_changing_epidemiology_of_Acinetobacter_spp_producing_MA_2015.PDF (612.23 KB)
Citações na Scopus
43
Tipo de produção
article
Data de publicação
2015
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
VASCONCELOS, Ana Tereza R.
BARTH, Afonso L.
ZAVASCKI, Alexandre P.
GALES, Ana C.
LUCAREVSCHI, Bianca R.
CABRAL, Blenda G.
BRASILIENSE, Danielle M.
FURTADO, Guilherme H. C.
Citação
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, v.83, n.4, p.382-385, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We evaluated the epidemiology of Acinetobacter spp. recovered from patients diagnosed with bloodstream infections in 9 tertiary hospitals located in all Brazilian geographic regions between April and August 2014. Although OXA-23-producing Acinetobacter baumannii clones were disseminated in most hospitals, it was observed for the first time the spread of OXA-72 among clonally related A. baumannii isolated from distinct hospitals. Interestingly, Acinetobacter pittii was the most frequent species found in a Northern region hospital. Contrasting with the multisusceptible profile displayed by A. pittii isolates, the tetracyclines and polymyxins were the only antimicrobials active against all A. baumannii isolates.
Palavras-chave
Acinetobacter spp, OXA carbapenemase, Bloodstream infections, Molecular epidemiology
URI
https://observatorio.fm.usp.br/handle/OPI/12708
Referências
  1. Werneck JS, 2011, J ANTIMICROB CHEMOTH, V66, P452, DOI 10.1093/jac/dkq462
  2. Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026
  3. Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428
  4. Antonio CS, 2011, ANTIMICROB AGENTS CH, V55, P1322, DOI 10.1128/AAC.01102-10
  5. Fortaleza CMCB, 2014, INFECT CONT HOSP EP, V35, P85, DOI 10.1086/674392
  6. Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x
  7. La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006
  8. Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032
  9. Chagas TPG, 2014, DIAGN MICR INFEC DIS, V79, P468, DOI 10.1016/j.diagmicrobio.2014.03.006
  10. Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007
  11. Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014
  12. Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406
  13. Stietz MS, 2013, INFECT GENET EVOL, V14, P294, DOI 10.1016/j.meegid.2012.12.020
  14. Gionco B, 2012, J ANTIMICROB CHEMOTH, V67, P2531, DOI 10.1093/jac/dks223
  15. Mostachio AK, 2012, INT J ANTIMICROB AG, V39, P396, DOI 10.1016/j.ijantimicag.2012.01.021
  16. Brazilian Health Surveillance Agency (ANVISA), B INF SEG QUAL SERV
  17. CLSI, 2014, M100S24 CLSI
  18. de Sá Cavalcanti Felipe Lira, 2013, Diagn Microbiol Infect Dis, V77, P250, DOI 10.1016/j.diagmicrobio.2013.07.022
  19. Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034
  20. European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS
  21. Fisman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114548
  22. Wemeck JS, 2011, ANTIMICROB AGENTS CH, V55, P4494

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/54